This book provides an insider’s overview of the emerging Chinese biopharma sector, its dynamics and trends, first bust and boom cycle, long-term perspectives, and how as a foreign company or investor to tap into this. China has gone from a country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of the world. The Chinese biopharma sector is only a decade old, but it already has become a new driver of growth and value. The b...

Description (513 / 2500)Queero follows the journey of an LGBTQ+ youth from the awkward uncertainty of grade school to full self-acceptance; aided on their journey by Queero, a popular, cis/straight ally and peer who provided support and advocacy for young Yolanda. From her youth til this day, Queero supports and cares for the LGBTQ+ youth in the same small town. The text of this book is taken from an autobiographical the song "Queero" by Reverend Yolanda Mapes. Reverend Yolanda flaw...

Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biot...

Is your portfolio in peak health?Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.”Health-Care Investing provides a tho...

Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to...

Principles of Pharmaceutical Marketing, Third Edition offers the perspectives of both those who teach and those who practice pharmaceutical marketing. This reflects the need for and the effort to provide the most relevant “real world” approach to this complex and fascinating field. This text is designed for undergraduate students in pharmacy whose background in marketing is limited, those actually involved in pharmaceutical marketing, and anyone desiring an introduction to the intricacies ...

“During a time of tremendous change and uncertainty, Healthcare Disrupted gives executives a framework and language to determine how they will evolve their products, services, and strategies to flourish in a increasingly value-based healthcare system. Using a powerful mix of real world examples and unanswered questions, Elton and O’Riordan lead you to see that ‘no action’ is not an option—and push you to answer the most important question: ‘What is your role in this digitally driven change...

The book is divided into eight chapters that covers key aspects of pharmaceutical market access in emerging markets. From understanding the healthcare environment, to the personal and organizational mindset, to pricing, market access solutions and negotiations. The book is based on practical experience that gives the reader knowledge and know-how to apply practical market access solutions to improve access to innovative medicine in emerging markets.

An Essential Guide to the Processes and Operational Complexities of the U.S. Healthcare SystemA Doody's Core Title for 2024 & 2023!The U.S. Healthcare Ecosystem serves as an expert navigator through the complicated and often confusing environment where healthcare payers, healthcare providers, and producers of healthcare technologies all interact. This thorough resource provides expert insight and analysis of employer-based health i...

”Because at the heart of the apparent conflict between public health concerns and capitalistic interests, market access for pharmaceuticals is largely driven by political considerations, the difference with usual consumer goods being that pharmaceuticals are saving lives or years of life in good health”.If pharmaceutical companies are to innovate, they must be incentivised with prices that reflect the value of their products, and the resources and risks involved in their production...

The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the w...

“Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she’s written a book on how she went about it.”—Wall Street Journal"For anyone who invests in health, works in health tech or simply cares about where this industry is headed, this is a smart and necessary read."—Entrepreneur"One of the most accessible...